Laddar...
Population Pharmacokinetics of Blinatumomab in Pediatric and Adult Patients with Hematological Malignancies
BACKGROUND AND OBJECTIVES: Blinatumomab (BLINCYTO(®)) is a novel bispecific T cell engager (BiTE(®)) approved in the USA for the treatment of relapsed or refractory B cell precursor acute lymphoblastic leukemia (ALL) in children and adults, as well as minimal residual disease ALL in adults. This ana...
Sparad:
| I publikationen: | Clin Pharmacokinet |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer International Publishing
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7109194/ https://ncbi.nlm.nih.gov/pubmed/31679130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-019-00823-8 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|